Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Future Oncology (London, England)|May 2, 2023
A phase II trial to assess the efficacy and safety of ropeginterferon α-2b in Chinese patients with polycythemia veraJie Jin, Albert Qin, Lei Zhang, et al.
Cancers|September 14, 2024
A Novel Monoclonal Antibody against PD-1 for the Treatment of Viral Oncogene-Induced Tumors or Other CancerXu Xu, Shih-Long Yan, Yi-Te Yo, et al.
British Journal of Clinical Pharmacology|December 15, 2021
Novel long-acting ropeginterferon alfa-2b: Pharmacokinetics, pharmacodynamics and safety in a phase I clinical trialYi-Wen Huang, Albert Qin, Jane Fang, et al.
Advances in Therapy|July 30, 2021
Pharmacokinetics and Pharmacodynamics of Novel Long-Acting Ropeginterferon Alfa-2b in Healthy Chinese SubjectsYi-Wen Huang, Chan-Yen Tsai, Chung-Wei Tsai, et al.
Journal of Pharmacokinetics and Pharmacodynamics|March 20, 2024
Oral docetaxel plus encequidar - A pharmacokinetic model and evaluation against IV docetaxelDavid Wang, Chris Jackson, Noelyn Hung, et al.
Cancer Chemotherapy and Pharmacology|May 30, 2024
Oral docetaxel plus encequidar - a phase 1 clinical trialDavid Wang, Noelyn Hung, Tak Hung, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|September 4, 2023
A therapeutic dose and its pharmacokinetics of ropeginterferon Alfa-2b for hepatitis C treatmentChing-Chu Lo, Wan-Long Chuang, Hsing-Tao Kuo, et al.
British Journal of Clinical Pharmacology|March 19, 2024
Exposure-efficacy and exposure-safety analyses of ropeginterferon alfa-2b treatment in patients with polycythaemia veraAlbert Qin, Daoxiang Wu, Yaning Li, et al.
Annals of Hematology|August 15, 2024
A randomized, double-blind, placebo-controlled phase 3 study to assess efficacy and safety of ropeginterferon alfa-2b in patients with early/lower-risk primary myelofibrosisGhaith Abu-Zeinah, Albert Qin, Harinder Gill, et al.
Pharmaceutics|May 25, 2024
A Sensitive Assay for Unbound Docetaxel Using Ultrafiltration plus HPLC-MS and Its Application to a Clinical StudyDavid Wang, Natalie Hughes-Medlicott, Lilian Klingler, et al.
Pageof 5